Abstract: To provide a reproduction method for enabling an automatic selection and reproduction of a music data suitable for a user's preference during the reproduction, for reproducing a contents data given with an attribute data, and having the steps of: reproducing a plurality of the contents data in a predetermined pattern successively; monitoring an execution of a predetermined input operation during reproducing the contents data; specifying an attribute data common to the plurality of the contents data, to which the input operation is not executed during the reproduction, when a number of the input operations exceeds a predetermined value; and reproducing a contents data given with the common attribute data.

Abstract: A vehicle body structure for efficiently transmitting and dispersing collision energy is provided. The vehicle body structure includes a floor tunnel provided in the center of the vehicle width and extending longitudinally of a vehicle body. Side portions of the floor tunnel are joined to floor frame members provided on the right and left thereof. A rear portion of the floor tunnel is joined to center frame members provided rearward thereof. Collision energy acting on the front end of the floor tunnel is transmitted and dispersed to the right and left floor frame members and the center frame members. Collision energy acting on the floor frame members is transmitted and dispersed to the floor tunnel and the center frame members. Collision energy transmitted to the center frame members is transmitted and dispersed through a plurality of crossmembers disposed rearward of the floor tunnel to the rear of the vehicle body.

Abstract: A medicinal oral preparation to be delivered to the large intestine comprising a core containing a pharmacologically active ingredient, an inner layer containing one or more cationic polymers and an outer layer containing one or more anionic polymers whereby the core is coated, which is designed so that, in a disintegration test successively consisting of a vertical movement for 2 hours in a first solution of pH 1.2, a vertical movement for 2 hours in a second solution of pH 7.4 and a vertical movement in a third solution of pH 6.4, the average disintegration initiation point and the average disintegration completion point each falls within a period from 35 minutes to 130 minutes after starting the vertical movement in the third solution.

Abstract: Provided in a phosphate ion adsorbent containing a weakly basic anion exchange resin as an active ingredient which aims at providing preventives and/or remedies for hyperphosphatemia having a high selectivity for the adsorption of phosphate ion and showing an effect of lowering blood phosphorus level and another effect of suppressing phosphorus excretion into the urine.

Abstract: A video signal generator adds a digital luminance signal to a digital chrominance signal including a color burst to obtain a digital composite video signal. A selector selects the digital luminance signal for a monochrome picture and the digital composite video signal for a color picture. A digital-to-analog converter converts the selected signal to an analog signal, which is output from a composite video output terminal. The selection may be made by comparing the digital chrominance signal with a threshold to decide whether the digital luminance and chrominance signals represent a monochrome picture or a color picture. For a monochrome picture, the output signal includes no color burst and is free of color noise. A receiving device can reproduce the monochrome picture faithfully without the need for a separate-video input connector or color burst suppression circuitry.

Abstract: To provide medicinal compositions containing an active ingredient which has a low molecular weight, is free from any side effects and has an effect of potentiating nerve growth factor activity and utilization thereof for treating diseases associated with dementia, medicinal preparations containing an effective amount of vitamin K and/or its derivative showing an effect of potentiating nerve growth factor activity are provided.

Abstract: In a vehicle steering apparatus, front wheels are controlled to be turned by a computer program processing. A displacement/torque conversion section 51 converts a steering angle ? into a steering torque Td that is in relation of exponential function. A torque/lateral-acceleration conversion section 52, torque/yaw-rate conversion section 53 and torque/curvature conversion section 54 convert into an anticipated lateral acceleration Gd, anticipated yaw rate ?d and anticipated turning curvature ?d based upon the steering torque Td. Turning angle conversion sections 55, 56 and 57 calculate target turning angles ?g, ?y and ?p. A turning angle deciding section 58 decides a target turning angle ?d among the target turning angles ?g, ?y and ?p according to the detected vehicle speed V. A turning control section 60 controls the steered wheels to be turned into the target turning angle ?d.

Abstract: In a vehicle steering apparatus, front wheels are controlled to be turned by a computer program processing. A displacement/torque conversion section 51 converts a steering angle ? into a steering torque Td that is in relation of exponential function. A torque/lateral-acceleration conversion section 52 converts into an anticipated lateral acceleration Gd based upon the steering torque Td. A turning angle conversion section 55 calculates target turning angles ?d. A turning angle correcting section 61 obtains a slip angle ? of a slip generated on a vehicle. Then, the turning angle correcting section 61 corrects the target turning angle ?d based upon the obtained slip angle ?, thereby calculating a corrected target turning angle ?da. A drive control section 63 controls the steered wheels to be turned into the corrected target turning angle ?da. According to this, a driver can correctly perceive the generated anticipated lateral acceleration Gd, whereby he/she can easily drive the vehicle.

Abstract: Objects of the present invention are to provide a continuous emulsification process and equipment therefor in which exact viscosity is measured inline and production conditions are controlled automatically, and a continuous production method for process cheese type and equipment therefor.

Abstract: A microarray for predicting the prognosis of neuroblastoma, wherein the microarray has 25 to 45 probes related to good prognosis, which are hybridized to a gene transcript whose expression is increased in a good prognosis patient with neuroblastoma and are selected from 96 polynucleotides consisting of the nucleotide sequences of Seq. ID No. 1 to 96 or their partial continuous sequences or their complementary strands, and 25 to 45 probes related to poor prognosis, which are hybridized to a gene transcript whose expression is increased in a poor prognosis patient with neuroblastoma and are selected from 104 polynucleotides consisting of the nucleotide sequences of Seq. ID No. 97 to 200 or their partial continuous sequences or their complementary strands.

Abstract: A method for determining a position of a reference point in which there is no influence of aberration of a camera lens or the like, but an error caused by a failure in shape of an alignment mark can be reduced. An alignment mark consisting of a plurality of pattern portions (and background portions) centering at a design reference point is provided in advance. Positions of centers of border lines of the patterns are calculated. Obtained coordinate values of the centers are averaged in each axial direction. The averaged coordinate values are regarded as coordinate values of a machining reference point. Thus, even when a defect occurs in any pattern portion, an error caused by the defect is reduced so that the accuracy in machining can be improved.

Abstract: Agents potentiating nerve growth factor activity are provided for treating Alzheimer's disease which contain as the active ingredient dodecatrienoic acid derivatives represented by the general formula (I): wherein X represents hydrogen, CHO, COOH, COOR (wherein R represents an ester residue or an addition salt comprising an alkali metal salt or an organic acid salt group), provided that in case where X is COOH, it is bonded to the carbon atom at the position marked with * so as to form a lactam O?C—O—.

Abstract: A medicament for treating neurodegenerative diseases, comprising as an active ingredient selenoprotein P and/or a peptide fragment or a series of peptide fragments derived from the C-terminal of selenoprotein P. An excellent medicament for treating neurodegenerative diseases, especially suitable for treating neurodegenerative diseases with ataxia as a principal symptom is provided.

Abstract: A peptide fragment or a series of peptide fragments containing one or more selenocysteine that has a lowered toxicity than selenocystine and that exhibits a cytotoxicity-inhibitory activity. The peptide fragment or a series of peptide fragments according to the present invention has preferably the amino acid sequence from 260th to 362nd amino acid residues from the C-terminal of selenoprotein P, or said amino acid sequence with one or several amino acid residues therein being deleted, substituted or added, or a partial sequence of either of the above amino acid sequences, or an amino acid sequence comprising as a part any of the above amino acid sequences. A screening method for a peptide fragment having the cytotoxicity-inhibitory activity is also provided.

Abstract: Provided in a phosphate ion adsorbent containing a weakly basic anion exchange resin as an active ingredient which aims at providing preventives and/or remedies for hyperphosphatemia having a high selectivity for the adsorption of phosphate ion and showing an effect of lowering blood phosphorus level and another effect of suppressing phosphorus excretion into the urine.

Abstract: A vehicle body structure for efficiently transmitting and dispersing collision energy is provided. The vehicle body structure includes a floor tunnel provided in the center of the vehicle width and extending longitudinally of a vehicle body. Side portions of the floor tunnel are joined to floor frame members provided on the right and left thereof. A rear portion of the floor tunnel is joined to center frame members provided rearward thereof. Collision energy acting on the front end of the floor tunnel is transmitted and dispersed to the right and left floor frame members and the center frame members. Collision energy acting on the floor frame members is transmitted and dispersed to the floor tunnel and the center frame members. Collision energy transmitted to the center frame memerbs is transmitted and dispersed through a plurality of crossmembers disposed rearward of the floor tunnel to the rear of the vehicle body.

Abstract: A protective member for protecting electric wires includes: a non-woven cloth layer having flexibility and made of a chlorine-free resin; and an outer resin layer laminated monolithically on outer surface of the non-woven cloth layer, and made of a chlorine-free and fire-retardant resin, wherein a thickness of the outer resin layer is configured to be not more than a thickness of the non-woven cloth layer, and wherein a total thickness of the non-woven cloth layer and the outer resin layer is configured to have a predetermined wear resistance.

Abstract: An cross-linked anion exchange resin or a salt thereof obtained by reacting a polymer (A) having amino and/or imino groups in the total number of two or more per molecule with a compound (B) having two or more functional groups capable of reacting with amino and/or imino group contained in the polymer (A). The resin or salt has a water absorption ratio of 4.0 or lower.

Abstract: A semiconductor device manufacture method includes the steps of forming a resist layer above a work target layer; exposing and developing the resist layer to form resist patterns including isolated pattern and dense patterns; monitoring widths of isolated and dense pattern of the resist patterns to determine trimming amounts of linewidths to be reduced; determining etching conditions for realizing the trimming amounts of both the isolated and dense patterns, the etching conditions using mixed gas of a gas having a function of mainly enhancing etching and a gas having a function of mainly suppressing etching; trimming the resist pattern under said determined etching conditions; and etching the work target layer by using said trimmed resist patterns. A desired pattern width an be realized stably by trimming using plasma etching.

Abstract: Percutaneous absorption preparations for treating dementia which contain an adhesive composition, characterized in that the adhesive composition contains the active ingredient in a dispersed state, the active ingredient is released at a pharmacologically effective rate and the skin permeation rate thereof is at least 1.2 &mgr;g/cm2/h. Thus, it is possible to provide percutaneous absorption preparations whereby the therapeutic effect can be sustained over a prolonged period of time without elevating the concentration of the active ingredient in the plasma to such a level as causing the expression of side effects in the administration of remedies for dementia.